• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Patient Self-Monitoring: Devices, Markets, Players and Prospects - Product Image

Patient Self-Monitoring: Devices, Markets, Players and Prospects

  • Published: June 2013
  • Greystone Associates

The ability of patients to monitor their own serum levels is deemed to be a critical tool in reducing the pathological effects of poorly controlled disease factors. For conditions other than diabetes, the vast majority of monitoring has until recently been performed in physician offices or similar healthcare settings.

The convergence of new measurement technologies, patient demographics and managed care cost initiatives is driving patient monitoring for a number of conditions from caregiver facilities and into homes. In the process, patient self-monitoring for cholesterol, INR and hypertension have the potential to transition from a cottage industry into a significant market. The key enabler of this significant shift will be technological advances that will provide accurate readings in a format that consumers can understand, clearly indicating when a follow-up visit to a caregiver is needed. Systems that allow patients to share readings with physicians electronically have already been introduced. Ultimately, the success of this self-test market will rely on monitors that can provide accurate values for the various analytes that are associated with health risk, presenting them READ MORE >

Executive Summary

Disease Management Market Dynamics

Patient Monitoring Overview
Key Factors in Patient Compliance
Market Drivers
Shifting Patient Demographics
Industry Alignment and Competitive Landscape

Self-Monitoring Technology Strategies

Needle-Stick Tests
Self-Collected / Mail-in Tests
Combination Meters
Continuous Monitors
Future Developments
Noninvasive Monitors
Signal Processing Advances

Monitor Product Design & Patient Issues

Measurement Frequency
Patient/User Interface
Measurement Electronics
Sensor Technology

Self-Monitoring Therapeutic Segments

Atherosclerosis/Heart Disease (Cholesterol)
Diabetes (Glucose)
Heart Valve Replacement/Thrombosis
Hypertension (Blood Pressure)

Self-Monitoring Product Segment Analysis

Cholesterol Monitors
Coagulation Monitoring
Glucose Monitors
Traditional Meters
Continuous Monitors
Noninvasive Glucose Monitors
Combination Monitors
Potential/Emerging Self-Monitoring Segments

Market Factors

Clinical Trial Issues
Regulations and Guidance
Managed care/Reimbursement
Patient Compliance
Sourcing/Private Labeling

Patient Self-Monitoring - Company Profile

Note: Product cover images may vary from those shown


Our Clients

Our clients' logos